This website uses cookies

We use cookies to personalize content and ads, and to analyze our traffic and improve our service.

Cookies that the site cannot function properly without. This includes cookies for access to secure areas and CSRF security. Please note that Craft’s default cookies do not collect any personal or sensitive information. Craft's default cookies do not collect IP addresses. The information they store is not sent to Pixel & Tonic or any 3rd parties.
Name: CraftSessionId
Description: Craft relies on PHP sessions to maintain sessions across web requests. That is done via the PHP session cookie. Craft names that cookie “CraftSessionId” by default, but it can be renamed via the phpSessionId config setting. This cookie will expire as soon as the session expires.
Provider: this site
Expiry: Session
Name: *_identity
Description: When you log into the Control Panel, you will get an authentication cookie used to maintain your authenticated state. The cookie name is prefixed with a long, randomly generated string, followed by _identity. The cookie only stores information necessary to maintain a secure, authenticated session and will only exist for as long as the user is authenticated in Craft.
Provider: this site
Expiry: Persistent
Name: *_username
Description: If you check the "Keep me logged in" option during login, this cookie is used to remember the username for your next authentication.
Provider: this site
Expiry: Persistent
Name: CRAFT_CSRF_TOKEN
Description: Protects us and you as a user against Cross-Site Request Forgery attacks.
Provider: this site
Expiry: Session
Statistic cookies help us understand how visitors interact with websites by collecting and reporting information anonymously.
Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
Details Hide Details
Pontus Pharma
  • Početna
  • O Colosalu
  • Stručni kutak
    • Glavni sastojci
    • Crijevni problemi
  • Zanimljivosti
  • Kontakt
  • flag flag-hr HR
    HRHR SRBSRB BiHBiH

Izvori iz međunarodne literature

  • Pontus Pharma
  • Colosal
  • Colosal
  • Izvori iz međunarodne literature
Mikrobiologija 002

* Izvori iz međunarodne literature

  1. Aguirre, M. & Collins, M.D. (1993). Lactic acid bacteria and human clinical infections. J. Appl. Bact. 75:95-107.
  2. Bartosch, S., Woodmansey, E.J., Paterson, J.C.M., McMurdo, M.E.T. & Macfarlane, G.T. (2005). Microbiological effects of consuming a symbiotic containing Bifidobacterium bifidum, bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerise chain reaction and counting of viable bacteria. Clinical Infectious Diseases. 40:28-37.
  3. Boyle, R.J., Robins-Browne, R.M. & Tang, M.L. (2006). Probiotic use in clinical practice: what are the risks? Am J. Clin Nutr. 83(6):1256-64.
  4. Borriello, S.R, Hammes, W.P.,, Holzapfel, W., Marteau, P, Schrezenmeir, J., Vaara, M. & Valtonen, V. (2008). Safety of probiotics that contain lactobacilli or bifidobacteria. Clin. Infect Dis. 36:775-780.
  5. Buda, A., Qualtrough, D., Jepson, M.A., Martines, D., Paraskeva, C., Pignatelli, M. Butyrate downregulates a2ß1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell lines. Article in Gut • (2003)52: pp. 729–734.
  6. Delcour, J., Ferain, T., Deghorain, M., Palumbo, E. & Hols, P. (1999). The biosynthesis and functionality of the cellwall of lactic acid bacteria. Antonie Van Leeuwenhoek. 76(1-4):159-84.15. slide
  7. Di Sabatino A, Morera R, Ciccocioppo R, Cazzola P, Gotti S, Tinozzi FP, Tinozzi S, Corazza GR. Oral butyrate for mildly to moderately active Crohn's disease. Aliment Pharmacol Ther. 2005 Nov 1;22(9):789-94. doi: 10.1111/j.1365-2036.2005.02639.x. PMID: 16225487.
  8. Foligne, B., Nutten, S., Grangette, C., Dennin, V., Goudercourt, D., Poiret, S., Dewulf, J., Brassart, D., Mercenier, A., & Pot, B. (2007). Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World Journal of Gastroenterology. 13(2):236-243.
  9. Gaudier, E., Jarry, A., Blottie`re, H.M., De Coppet, P., Buisine, M.P., Aubert, J.P., Laboisse, C., Cherbut, C., and Hoebler, C., Butyrate specifically modulates MUC gene expression in intestinal epithelial goblet cells deprived of glucose. Am J Physiol Gastrointest Liver Physiol.( 2004) 287: pp. G1168–G1174.
  10. Hallert, C., Björck, I., Nyman, M., Pousette, A., Grännö, C. and Svensson, H. Increasing Fecal Butyrate in Ulcerative Colitis Patients by Diet: Controlled Pilot Study. Inflammatory Bowel Diseases; Crohn’s & Colitis Foundation of America, (2003) pp. 116–121.
  11. Lammers, K.M., Brigidi, P., Vitali, B., Gionchetti, P, Rizello, F, Caramelli, E., Matteuzzi, D. & Campieri, M. (2003). Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunology and Medical Microbiology. 38:165-172.
  12. Masco, L., Ventura, M., Zink, R., Huys, G. & Swings, J. (2004). Polyphasic taxonomic analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the subspecies level: reclassification of Bifidobacterium animalis subsp. Animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. Lactis subsp. nov. Int. J. Syste. Evol. Microbiol. 54:1137-1143.
  13. Meile, L., Ludwig, W., Rueger, U., Gut, C., Kaufmann, P, Dasen, G., Wenger, S. & Teuber, M. (1997). Bifidobacterium lactis sp. nov., a moderately oxygen tolerant species isolated from fermented milk. Syst. Appl. Microbiol. 20:57-64.
  14. Mitsuoka, T. (1996). Intestinal flora and human health. Asia Pacific J.Clin. Nutr. 5:2-9.
  15. Resta-Lenert, S., Truong, F., Barrett, K.E. and Eckmann I. Inhibition of epithelial chloride secretion by butyrate: role of reduced adenylyl cyclase expression and activity. Am J Physiol Cell Physiol (2001) 281: pp. C1837–C1849.
  16. Ruemmele, F.M., Schwartz, S., Seidman, E.G., Dionne, S., Levy, E., Lentze, M.J. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut (2003);52: pp.94–100.
  17. Salminen, S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W.M., Fonden, R., Saxelin, M., Collins, K., Mogensen, G., Birkeland, S.-E. & Mattila- Sandholm, T. (1998). Demonstration of safety of probiotics-a review. Int. J. Food Prot. 44:93-106.
Kontakt info

Pontus Pharma d.o.o.
A: Ulica kralja Zvonimira 62, 10000 Zagreb
E: info@pontus-pharma.com
T: +385 (0)1 7709007

Pontus Pharma

© Copyright 2021. All Rights Reserved. Uvjeti

Izrada web stranica | CMS | Hosting | SEO